TITLE

WS2–4IDENTIFICATION OF ACTIONABLE MUTATIONS IN SPECIMENS FROM PATIENTS WITH LUNG CANCER AT SHIZUOKA CANCER CENTER

AUTHOR(S)
Kenmotsu, H.; Koh, Y.; Serizawa, M.; Isaka, M.; Mori, K.; Takahashi, T.; Endo, M.; Nakajima, T.; Ohde, Y.; Yamamoto, N.
PUB. DATE
November 2013
SOURCE
Annals of Oncology;Nov2013 Supplement 9, Vol. 24, pix27
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
92604604

 

Related Articles

  • Identification of new ALK and RET gene fusions from colorectal and lung cancer biopsies. Lipson, Doron; Capelletti, Marzia; Yelensky, Roman; Otto, Geoff; Parker, Alex; Jarosz, Mirna; Curran, John A; Balasubramanian, Sohail; Bloom, Troy; Brennan, Kristina W; Donahue, Amy; Downing, Sean R; Frampton, Garrett M; Garcia, Lazaro; Juhn, Frank; Mitchell, Kathy C; White, Emily; White, Jared; Zwirko, Zac; Peretz, Tamar // Nature Medicine;Mar2012, Vol. 18 Issue 3, p382 

    Applying a next-generation sequencing assay targeting 145 cancer-relevant genes in 40 colorectal cancer and 24 non-small cell lung cancer formalin-fixed paraffin-embedded tissue specimens identified at least one clinically relevant genomic alteration in 59% of the samples and revealed two gene...

  • Development of a semi-conductor sequencing-based panel for genotyping of colon and lung cancer by the Onconetwork consortium. Tops, Bastiaan B. J.; Normanno, Nicola; Kurth, Henriette; Amato, Eliana; Mafficini, Andrea; Rieber, Nora; Le Corre, Delphine; Rachiglio, Anna Maria; Reiman, Anne; Sheils, Orla; Noppen, Christoph; Lacroix, Ludovic; Cree, Ian A.; Scarpa, Aldo; Ligtenberg, Marjolijn J. L.; Laurent-Puig, Pierre // BMC Cancer;2015, Vol. 15 Issue 1, p1 

    Background: The number of predictive biomarkers that will be necessary to assess in clinical practice will increase with the availability of drugs that target specific molecular alterations. Therefore, diagnostic laboratories are confronted with new challenges: costs, turn-around-time and the...

  • Cytokeratin 7 and 20 staining for the diagnosis of lung and colorectal adenocarcinoma. Kummar, S.; Fogarasi, M.; Canova, A.; Mota, A.; Ciesielski, T. // British Journal of Cancer;6/17/2002, Vol. 86 Issue 12, p1884 

    The origin of metastatic adenocarcinoma lesions can sometimes be difficult to diagnose. The objectives of our study were to establish the cytokeratin staining pattern of primary and metastatic lung and colorectal adenocarcinomas, and to determine if this helps to identify the site of origin of...

  • Gene defects may predict colon cancer.  // Newsweek;8/24/1987, Vol. 110 Issue 8, p46 

    British researchers recently announced they have found a genetic abnormality linked to colon cancer. A specific genetic pattern, or `marker' has been identified on the fifth of the 23 pairs of chromosomes found in every living cell. At least 25 percent of patients studied who had colon cancer...

  • `Colon gene' rounds off a brilliant year. Miller, Susan Katz // New Scientist;12/11/93, Vol. 140 Issue 1903, p4 

    Reports on the isolation of the first gene for a common form of cancer known as hereditary nonpolyposis colon cancer. Involvement of two research teams in finding the gene; Techniques used to identify the gene; Implications for medical genetic research; Call for people who are interested to be...

  • Medicine: Finding the colon cancer gene.  // Newsweek;12/13/1993, Vol. 122 Issue 24, p72 

    Cites a report in the journal `Cell' last week that two research teams have isolated the gene involved in hereditary colon cancer and determined how it works. The gene, known as MSH2; Colon tumors as the nation's second leading cause of cancer death; What the discovery means to people from...

  • Genetic defect is possible link to colorectal cancer. Reiman, Patty // Dermatology Times;Feb2000, Vol. 21 Issue 2, p11 

    Reports the possibility of a link between genetic defects in benign skin lesions and colorectal cancer in London, England. Etiology and pathophysiology of hereditary nonpolyposis colorectal cancer syndrome; Presence of microsatellite instability in benign skin lesions; Use of skin lesions as a...

  • Colorectal cancer. Dunlop, Malcolm G. // BMJ: British Medical Journal (International Edition);06/28/97, Vol. 314 Issue 7098, p1882 

    Focuses on the genetic susceptibility of individuals to colorectal cancer. Increase in colorectal cancer cases in Great Britain; Population lifetime risk of developing large bowel malignancy; Role of genetic susceptibility to the disease; Dominant gene disorders such as familial adenomatous...

  • RE: Cost-Effectiveness Analysis of Screening for KRAS and BRAF Mutations in Metastatic Colorectal Cancer. HESS, LISA M.; CARTER, GEBRA; SMOLEN, LEE; BOWMAN, LEE; VON HOHNHORST, PHILIPP; SEAGLE, CHRIS // JNCI: Journal of the National Cancer Institute;Feb2014, Vol. 106 Issue 2, p1 

    A letter to the editor is presented in response to the article "Cost-Effectiveness Analysis of Screening for KRAS and BRAF Mutations in Metastatic Colorectal Cancer" by A. S. Behl and colleagues published in the journal in 2012.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics